The Food and Drug Administration (FDA) recently approved lenacapavir for HIV prevention in both men and women. Many experts believe this twice a year treatment could be a game changer in the fight ...

The injectable HIV prevention treatment Yetzugo, made by Gilead Sciences, has received FDA approval, offering a twice-yearly ...

The Food and Drug Administration has approved a highly effective new HIV-prevention medication, Gilead Sciences reported Wednesday.

A breakthrough discovery at the University of Virginia has found that medication commonly prescribed to treat HIV also could prevent Alzheimer’s and many other diseases. “The list is very long ...

A new UVA study finds that HIV drugs like NRTIs may reduce Alzheimer's risk by 10% annually, suggesting potential for repurposing in dementia prevention.

A class of HIV drugs known as nucleotide reverse transcriptase inhibitors (NRTIs) may help prevent Alzheimer’s disease, reducing risk by up to 13%, a new study suggests.

A class of HIV drugs known as nucleotide reverse transcriptase inhibitors (NRTIs) may help prevent Alzheimer’s disease, reducing risk by up to 13%, a new study suggests.

When growing gang violence and the kidnappings of healthcare workers forced Haiti’s leading organization in the treatment of HIV and AIDS-related illnesses to relocate operations from its main ...

Share on Pinterest Metformin, a common medication used to treat type 2 diabetes, may also help reduce the viral reservoir in people living with HIV who are undergoing antiretroviral therapy ...

Thanks to antiviral medications, HIV infection is no longer a death sentence. With a cocktail of drugs, people with HIV can keep the virus in check. Introduced more recently, PrEP, or pre-exposure ...

Scientists at Sanford Burnham Prebys have identified promising real-world links between common HIV drugs and a reduced incidence of Alzheimer’s disease. The study, led by Jerold Chun, M.D ...